Lucy Song

Ms. Song joined Burrill & Company in 2000 and works in all aspects of the evaluating and investing in human healthcare companies for the firm’s venture arm.
Prior to joining Burrill & Company, Ms. Song held positions at two early stage companies in the area of high-throughput functional genomics and gene expression analysis technology.
Ms. Song has a BA degree in Molecular and Cell Biology with an emphasis in Cell and Developmental Biology from the University of California, Berkeley.